BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iborra M, Bernuzzi F, Invernizzi P, Danese S. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. Autoimmun Rev. 2012;11:305-314. [PMID: 20627134 DOI: 10.1016/j.autrev.2010.07.002] [Cited by in Crossref: 118] [Cited by in F6Publishing: 120] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Russo E, Cinci L, Di Gloria L, Baldi S, D’ambrosio M, Nannini G, Bigagli E, Curini L, Pallecchi M, Andrea Arcese D, Scaringi S, Malentacchi C, Bartolucci G, Ramazzotti M, Luceri C, Amedei A, Giudici F. Crohn’s disease recurrence updates: first surgery vs. surgical relapse patients display different profiles of ileal microbiota and systemic microbial-associated inflammatory factors. Front Immunol 2022;13:886468. [DOI: 10.3389/fimmu.2022.886468] [Reference Citation Analysis]
2 Adamowicz M, Stukan I, Milkiewicz P, Bialek A, Milkiewicz M, Kempinska-Podhorodecka A. Modulation of Mismatch Repair and the SOCS1/p53 Axis by microRNA-155 in the Colon of Patients with Primary Sclerosing Cholangitis. Int J Mol Sci 2022;23:4905. [PMID: 35563301 DOI: 10.3390/ijms23094905] [Reference Citation Analysis]
3 Bayomy NR, Shaaban MA, Dawood AEAS, Habib MEA, Kamel MA. Correlation between circulating MicroRNA-142-5p expression and Hashimoto's thyroiditis diagnosis and autoimmunity symptoms prediction, pilot study. Gene Reports 2022;26:101470. [DOI: 10.1016/j.genrep.2021.101470] [Reference Citation Analysis]
4 Kasai M, Omae Y, Kawai Y, Shibata A, Hoshino A, Mizuguchi M, Tokunaga K. GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion. Sci Rep 2022;12:1332. [PMID: 35079012 DOI: 10.1038/s41598-021-04576-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Bayomy NR, Abo Alfottoh WM, Ali Eldeep SA, Ibrahim Mabrouk Mersal AMS, Abd El-Bary HMA, Abd El Gayed EM. Mir-142-5p as an indicator of autoimmune processes in childhood idiopathic nephrotic syndrome and as a part of MicroRNAs expression panels for its diagnosis and prediction of response to steroid treatment. Mol Immunol 2021;141:21-32. [PMID: 34785326 DOI: 10.1016/j.molimm.2021.11.004] [Reference Citation Analysis]
6 Moret-Tatay I, Cerrillo E, Hervás D, Iborra M, Sáez-González E, Forment J, Tortosa L, Nos P, Gadea J, Beltrán B. Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications. Clin Transl Gastroenterol 2021;12:e00416. [PMID: 34695034 DOI: 10.14309/ctg.0000000000000416] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Kazemi S, Mirzaei R, Sholeh M, Karampoor S, Keramat F, Saidijam M, Alikhani MY. microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment. Immun Inflamm Dis 2021. [PMID: 34449979 DOI: 10.1002/iid3.519] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Bahmani L, Baghi M, Peymani M, Javeri A, Ghaedi K. MiR-141-3p and miR-200a-3p are involved in Th17 cell differentiation by negatively regulating RARB expression. Hum Cell 2021;34:1375-87. [PMID: 34086186 DOI: 10.1007/s13577-021-00558-4] [Reference Citation Analysis]
9 Hornschuh M, Wirthgen E, Wolfien M, Singh KP, Wolkenhauer O, Däbritz J. The role of epigenetic modifications for the pathogenesis of Crohn's disease. Clin Epigenetics 2021;13:108. [PMID: 33980294 DOI: 10.1186/s13148-021-01089-3] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
10 Tufekci KU, Ercan I, Isci KB, Olcum M, Tastan B, Gonul CP, Genc K, Genc S. Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration. Immunol Lett 2021;233:20-30. [PMID: 33711331 DOI: 10.1016/j.imlet.2021.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Alikiaii B, Bagherniya M, Askari G, Johnston TP, Sahebkar A. The role of phytochemicals in sepsis: A mechanistic and therapeutic perspective. Biofactors 2021;47:19-40. [PMID: 33217777 DOI: 10.1002/biof.1694] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
12 Izadi M, Tahmasebi S, Pustokhina I, Yumashev AV, Lakzaei T, Alvanegh AG, Roshangar L, Dadashpour M, Yousefi M, Ahmadi M. Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients. Multiple Sclerosis and Related Disorders 2020;46:102466. [DOI: 10.1016/j.msard.2020.102466] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Song J, Zhao L, Li Y. Comprehensive bioinformatics analysis of mRNA expression profiles and identification of a miRNA-mRNA network associated with lupus nephritis. Lupus 2020;29:854-61. [PMID: 32437257 DOI: 10.1177/0961203320925155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Konstantinidis AΟ, Pardali D, Adamama-Moraitou KK, Gazouli M, Dovas CI, Legaki E, Brellou GD, Savvas I, Jergens AE, Rallis TS, Allenspach K. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease. BMC Vet Res 2020;16:69. [PMID: 32087719 DOI: 10.1186/s12917-020-02287-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
15 Zhang L, Wu H, Zhao M, Lu Q. Identifying the differentially expressed microRNAs in autoimmunity: A systemic review and meta-analysis. Autoimmunity 2020;53:122-36. [DOI: 10.1080/08916934.2019.1710135] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
16 Minacapelli CD, Bajpai M, Geng X, Van Gurp J, Poplin E, Amenta PS, Brant SR, Das KM. miR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis. Inflamm Bowel Dis 2019;25:78-84. [PMID: 30204869 DOI: 10.1093/ibd/izy279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
17 Czaja AJ. Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions. World J Gastroenterol 2019; 25(45): 6579-6606 [PMID: 31832000 DOI: 10.3748/wjg.v25.i45.6579] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
18 Wang Y, Jiang Y, Zhao L. miRNA-200b improves hepatic fibrosis induced by CCL4 by regulating toll-like receptor 4 in mice. J Cell Biochem 2019;120:13254-61. [PMID: 30924172 DOI: 10.1002/jcb.28599] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Khordadmehr M, Shahbazi R, Sadreddini S, Baradaran B. miR-193: A new weapon against cancer. J Cell Physiol 2019;234:16861-72. [PMID: 30779342 DOI: 10.1002/jcp.28368] [Cited by in Crossref: 20] [Cited by in F6Publishing: 32] [Article Influence: 6.7] [Reference Citation Analysis]
20 Segal JP, Mullish BH, Quraishi MN, Acharjee A, Williams HRT, Iqbal T, Hart AL, Marchesi JR. The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease. Therap Adv Gastroenterol 2019;12:1756284818822250. [PMID: 30719076 DOI: 10.1177/1756284818822250] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
21 Tang WJ, Peng KY, Tang ZF, Wang YH, Xue AJ, Huang Y. MicroRNA-15a - cell division cycle 42 signaling pathway in pathogenesis of pediatric inflammatory bowel disease. World J Gastroenterol 2018; 24(46): 5234-5245 [PMID: 30581272 DOI: 10.3748/wjg.v24.i46.5234] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
22 Yarani R, Mirza AH, Kaur S, Pociot F. The emerging role of lncRNAs in inflammatory bowel disease. Exp Mol Med 2018;50:1-14. [PMID: 30523244 DOI: 10.1038/s12276-018-0188-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 56] [Article Influence: 9.0] [Reference Citation Analysis]
23 Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, García F, Rodríguez-Cabezas ME, Gálvez J. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition. J Nutr Biochem 2018;61:129-39. [PMID: 30236870 DOI: 10.1016/j.jnutbio.2018.08.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
24 Fukata T, Mizushima T, Nishimura J, Okuzaki D, Wu X, Hirose H, Yokoyama Y, Kubota Y, Nagata K, Tsujimura N, Inoue A, Miyoshi N, Haraguchi N, Takahashi H, Hata T, Matsuda C, Kayama H, Takeda K, Doki Y, Mori M, Yamamoto H. The Supercarbonate Apatite-MicroRNA Complex Inhibits Dextran Sodium Sulfate-Induced Colitis. Mol Ther Nucleic Acids 2018;12:658-71. [PMID: 30092402 DOI: 10.1016/j.omtn.2018.07.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
25 Jadideslam G, Ansarin K, Sakhinia E, Alipour S, Pouremamali F, Khabbazi A. The MicroRNA-326: Autoimmune diseases, diagnostic biomarker, and therapeutic target. J Cell Physiol 2018;233:9209-22. [PMID: 30078204 DOI: 10.1002/jcp.26949] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
26 Mousavi MJ, Jamshidi A, Chopra A, Aslani S, Akhlaghi M, Mahmoudi M. Implications of the noncoding RNAs in rheumatoid arthritis pathogenesis. J Cell Physiol 2019;234:335-47. [DOI: 10.1002/jcp.26911] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
27 De Iudicibus S, Lucafò M, Vitulo N, Martelossi S, Zimbello R, De Pascale F, Forcato C, Naviglio S, Di Silvestre A, Gerdol M, Stocco G, Valle G, Ventura A, Bramuzzo M, Decorti G. High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients. Int J Mol Sci 2018;19:E1399. [PMID: 29738455 DOI: 10.3390/ijms19051399] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
28 Latini A, Ciccacci C, Novelli G, Borgiani P. Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility. Immunol Res 2017;65:811-27. [PMID: 28741258 DOI: 10.1007/s12026-017-8937-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
29 Czaja AJ. Epigenetic changes and their implications in autoimmune hepatitis. Eur J Clin Invest. 2018;48. [PMID: 29383703 DOI: 10.1111/eci.12899] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
30 Zöller M. Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease. Front Immunol 2018;9:137. [PMID: 29456536 DOI: 10.3389/fimmu.2018.00137] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
31 Cirillo F, Lazzeroni P, Catellani C, Sartori C, Amarri S, Street ME. MicroRNAs link chronic inflammation in childhood to growth impairment and insulin-resistance. Cytokine & Growth Factor Reviews 2018;39:1-18. [DOI: 10.1016/j.cytogfr.2017.12.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
32 Becker E, Bengs S, Aluri S, Opitz L, Atrott K, Rost F, Leonardi I, Stanzel C, Raselli T, Kasper S, Ruiz P, Rogler G. Large-Scale Integrative Analysis of Epigenetic Modifications Induced by Isotretinoin, Doxycycline and Metronidazole in Murine Colonic Intestinal Epithelial Cells. Epigenomes 2017;1:24. [DOI: 10.3390/epigenomes1030024] [Reference Citation Analysis]
33 Ciccacci C, Politi C, Biancone L, Latini A, Novelli G, Calabrese E, Borgiani P. Polymorphisms in MIR122, MIR196A2, and MIR124A Genes are Associated with Clinical Phenotypes in Inflammatory Bowel Diseases. Mol Diagn Ther. 2017;21:107-114. [PMID: 27718165 DOI: 10.1007/s40291-016-0240-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
34 Bordron A, Charras A, Le Dantec C, Renaudineau Y. [Influence of epigenetic in Sjögren's syndrome]. Rev Med Interne 2018;39:346-51. [PMID: 29054585 DOI: 10.1016/j.revmed.2017.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
35 Han X, Zhang J, Tan Y, Zhou G. Probiotics: A non-conventional therapy for oral lichen planus. Archives of Oral Biology 2017;81:90-6. [DOI: 10.1016/j.archoralbio.2017.04.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
36 Zhang B, Wang L, Zhou Y. Elevated microRNA-125b promotes inflammation in rheumatoid arthritis by activation of NF-κB pathway. Biomedicine & Pharmacotherapy 2017;93:1151-7. [DOI: 10.1016/j.biopha.2017.07.042] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
37 Cirillo F, Lazzeroni P, Sartori C, Street ME. Inflammatory Diseases and Growth: Effects on the GH-IGF Axis and on Growth Plate. Int J Mol Sci 2017;18:E1878. [PMID: 28858208 DOI: 10.3390/ijms18091878] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
38 Palmieri O, Creanza TM, Bossa F, Latiano T, Corritore G, Palumbo O, Martino G, Biscaglia G, Scimeca D, Carella M, Ancona N, Andriulli A, Latiano A. Functional Implications of MicroRNAs in Crohn's Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling. Int J Mol Sci 2017;18:E1580. [PMID: 28726756 DOI: 10.3390/ijms18071580] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
39 Ma F, Liu F, Ding L, You M, Yue H, Zhou Y, Hou Y. Anti-inflammatory effects of curcumin are associated with down regulating microRNA-155 in LPS-treated macrophages and mice. Pharm Biol 2017;55:1263-73. [PMID: 28264607 DOI: 10.1080/13880209.2017.1297838] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 10.8] [Reference Citation Analysis]
40 Park JH, Peyrin-Biroulet L, Eisenhut M, Shin JI. IBD immunopathogenesis: A comprehensive review of inflammatory molecules. Autoimmun Rev. 2017;16:416-426. [PMID: 28212924 DOI: 10.1016/j.autrev.2017.02.013] [Cited by in Crossref: 121] [Cited by in F6Publishing: 116] [Article Influence: 24.2] [Reference Citation Analysis]
41 Jendrek ST, Gotthardt D, Nitzsche T, Widmann L, Korf T, Michaels MA, Weiss KH, Liaskou E, Vesterhus M, Karlsen TH, Mindorf S, Schemmer P, Bär F, Teegen B, Schröder T, Ehlers M, Hammers CM, Komorowski L, Lehnert H, Fellermann K, Derer S, Hov JR, Sina C. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis. Gut 2017;66:137-44. [PMID: 27406039 DOI: 10.1136/gutjnl-2016-311739] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 7.4] [Reference Citation Analysis]
42 Béres NJ, Kiss Z, Sztupinszki Z, Lendvai G, Arató A, Sziksz E, Vannay Á, Szabó AJ, Müller KE, Cseh Á, Boros K, Veres G. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease. Dig Liver Dis 2017;49:378-87. [PMID: 28077249 DOI: 10.1016/j.dld.2016.12.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
43 Becker E, Bengs S, Aluri S, Opitz L, Atrott K, Stanzel C, Castro PAR, Rogler G, Frey-Wagner I. Doxycycline, metronidazole and isotretinoin: Do they modify microRNA/mRNA expression profiles and function in murine T-cells? Sci Rep 2016;6:37082. [PMID: 27853192 DOI: 10.1038/srep37082] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
44 Béres NJ, Szabó D, Kocsis D, Szűcs D, Kiss Z, Müller KE, Lendvai G, Kiss A, Arató A, Sziksz E, Vannay Á, Szabó AJ, Veres G. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:327-35. [PMID: 26752469 DOI: 10.1097/MIB.0000000000000687] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
45 Pierdomenico M, Cesi V, Cucchiara S, Vitali R, Prete E, Costanzo M, Aloi M, Oliva S, Stronati L. NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:315-326. [PMID: 26752466 DOI: 10.1097/MIB.0000000000000659] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 6.7] [Reference Citation Analysis]
46 Li H, Wang Y, Li YZ. MicroRNA-133a suppresses the proliferation, migration, and invasion of laryngeal carcinoma cells by targeting CD47. Tumour Biol 2016. [PMID: 27730543 DOI: 10.1007/s13277-016-5451-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
47 Tili E, Michaille JJ. Promiscuous Effects of Some Phenolic Natural Products on Inflammation at Least in Part Arise from Their Ability to Modulate the Expression of Global Regulators, Namely microRNAs. Molecules 2016;21:E1263. [PMID: 27657035 DOI: 10.3390/molecules21091263] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
48 Xie L, Zhou F, Liu X, Fang Y, Yu Z, Song N, Kong F. Serum microRNA181a: Correlates with the intracellular cytokine levels and a potential biomarker for acute graft-versus-host disease. Cytokine 2016;85:37-44. [DOI: 10.1016/j.cyto.2016.05.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
49 Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
50 Kalabat DY, Vitsky A, Scott W, Kindt E, Hayes K, John-Baptiste A, Huang W, Yang AH. Identification and Evaluation of Novel MicroRNA Biomarkers in Plasma and Feces Associated with Drug-induced Intestinal Toxicity. Toxicol Pathol 2017;45:302-20. [PMID: 27189632 DOI: 10.1177/0192623316644992] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
51 Zhu J, Zhang Y, Zhang W, Zhang W, Fan L, Wang L, Liu Y, Liu S, Guo Y, Wang Y, Yi J, Yan Q, Wang Z, Huang G. MicroRNA-142-5p contributes to Hashimoto's thyroiditis by targeting CLDN1. J Transl Med 2016;14:166. [PMID: 27277258 DOI: 10.1186/s12967-016-0917-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
52 Liang DY, Hou YQ, Luo LJ, Ao L. Altered expression of miR-92a correlates with Th17 cell frequency in patients with primary biliary cirrhosis. Int J Mol Med 2016;38:131-8. [PMID: 27246196 DOI: 10.3892/ijmm.2016.2610] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
53 Xu XM, Zhang HJ. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation. World J Gastroenterol 2016; 22(7): 2206-2218 [PMID: 26900285 DOI: 10.3748/wjg.v22.i7.2206] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 47] [Article Influence: 8.3] [Reference Citation Analysis]
54 Yang Y, Peng L, Ma W, Yi F, Zhang Z, Chen H, Guo Y, Wang L, Zhao LD, Zheng W, Li J, Zhang F, Du Q. Autoantigen-targeting microRNAs in Sjögren’s syndrome. Clin Rheumatol 2016;35:911-7. [DOI: 10.1007/s10067-016-3203-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
55 Hessam S, Sand M, Skrygan M, Gambichler T, Bechara FG. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients. J Dermatol Sci 2016;82:166-74. [PMID: 26917346 DOI: 10.1016/j.jdermsci.2016.02.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
56 Su CM, Huang CY, Tang CH. Characteristics of resistin in rheumatoid arthritis angiogenesis. Biomark Med 2016;10:651-60. [PMID: 26867862 DOI: 10.2217/bmm.15.125] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
57 Moret-Tatay I, Iborra M, Cerrillo E, Tortosa L, Nos P, Beltrán B. Possible Biomarkers in Blood for Crohn's Disease: Oxidative Stress and MicroRNAs-Current Evidences and Further Aspects to Unravel. Oxid Med Cell Longev 2016;2016:2325162. [PMID: 26823944 DOI: 10.1155/2016/2325162] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
58 Krissansen GW, Yang Y, McQueen FM, Leung E, Peek D, Chan YC, Print C, Dalbeth N, Williams M, Fraser AG. Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease. Inflamm Bowel Dis 2015;21:520-30. [PMID: 25628040 DOI: 10.1097/MIB.0000000000000285] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
59 Hu JY, Zhang J, Ma JZ, Liang XY, Chen GY, Lu R, Du GF, Zhou G. MicroRNA-155-IFN-γ Feedback Loop in CD4(+)T Cells of Erosive type Oral Lichen Planus. Sci Rep 2015;5:16935. [PMID: 26594049 DOI: 10.1038/srep16935] [Cited by in Crossref: 22] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
60 Loddo I, Romano C. Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis. Front Immunol. 2015;6:551. [PMID: 26579126 DOI: 10.3389/fimmu.2015.00551] [Cited by in Crossref: 166] [Cited by in F6Publishing: 169] [Article Influence: 23.7] [Reference Citation Analysis]
61 Dieli-crimi R, Cénit MC, Núñez C. The genetics of celiac disease: A comprehensive review of clinical implications. Journal of Autoimmunity 2015;64:26-41. [DOI: 10.1016/j.jaut.2015.07.003] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 11.1] [Reference Citation Analysis]
62 Churov AV, Oleinik EK, Knip M. MicroRNAs in rheumatoid arthritis: Altered expression and diagnostic potential. Autoimmunity Reviews 2015;14:1029-37. [DOI: 10.1016/j.autrev.2015.07.005] [Cited by in Crossref: 136] [Cited by in F6Publishing: 139] [Article Influence: 19.4] [Reference Citation Analysis]
63 Hosokawa K, Muranski P, Feng X, Keyvanfar K, Townsley DM, Dumitriu B, Chen J, Kajigaya S, Taylor JG, Hourigan CS, Barrett AJ, Young NS. Identification of novel microRNA signatures linked to acquired aplastic anemia. Haematologica 2015;100:1534-45. [PMID: 26354756 DOI: 10.3324/haematol.2015.126128] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
64 Jensen MD, Andersen RF, Christensen H, Nathan T, Kjeldsen J, Madsen JS. Circulating microRNAs as biomarkers of adult Crohn’s disease: . European Journal of Gastroenterology & Hepatology 2015;27:1038-44. [DOI: 10.1097/meg.0000000000000430] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
65 Honardoost MA, Naghavian R, Ahmadinejad F, Hosseini A, Ghaedi K. Integrative computational mRNA-miRNA interaction analyses of the autoimmune-deregulated miRNAs and well-known Th17 differentiation regulators: An attempt to discover new potential miRNAs involved in Th17 differentiation. Gene 2015;572:153-62. [PMID: 26307197 DOI: 10.1016/j.gene.2015.08.043] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
66 Tomankova T, Petrek M, Gallo J, Kriegova E. MicroRNAs: Emerging Regulators of Immune-Mediated Diseases. Scand J Immunol. 2012;75:129-141. [PMID: 21988491 DOI: 10.1111/j.1365-3083.2011.02650.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
67 Abuhatzira L, Xu H, Tahhan G, Boulougoura A, Schäffer AA, Notkins AL. Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2β, and GAD65. FASEB J 2015;29:4374-83. [PMID: 26148972 DOI: 10.1096/fj.15-273649] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
68 Däbritz J, Menheniott TR. Linking immunity, epigenetics, and cancer in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:1638-1654. [PMID: 24896241 DOI: 10.1097/mib.0000000000000063] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
69 Pathak S, Grillo AR, Scarpa M, Brun P, D’Incà R, Nai L, Banerjee A, Cavallo D, Barzon L, Palù G. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis. Exp Mol Med. 2015;47:e164. [PMID: 25998827 DOI: 10.1038/emm.2015.21] [Cited by in Crossref: 47] [Cited by in F6Publishing: 58] [Article Influence: 6.7] [Reference Citation Analysis]
70 Mirza AH, Berthelsen CH, Seemann SE, Pan X, Frederiksen KS, Vilien M, Gorodkin J, Pociot F. Transcriptomic landscape of lncRNAs in inflammatory bowel disease. Genome Med. 2015;7:39. [PMID: 25991924 DOI: 10.1186/s13073-015-0162-2] [Cited by in Crossref: 97] [Cited by in F6Publishing: 108] [Article Influence: 13.9] [Reference Citation Analysis]
71 Su CM, Hsu CJ, Tsai CH, Huang CY, Wang SW, Tang CH. Resistin Promotes Angiogenesis in Endothelial Progenitor Cells Through Inhibition of MicroRNA206: Potential Implications for Rheumatoid Arthritis. Stem Cells 2015;33:2243-55. [PMID: 25828083 DOI: 10.1002/stem.2024] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
72 Li P, Spolski R, Liao W, Leonard WJ. Complex interactions of transcription factors in mediating cytokine biology in T cells. Immunol Rev. 2014;261:141-156. [PMID: 25123282 DOI: 10.1111/imr.12199] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 9.7] [Reference Citation Analysis]
73 Naghavian R, Ghaedi K, Kiani-Esfahani A, Ganjalikhani-Hakemi M, Etemadifar M, Nasr-Esfahani MH. miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis. PLoS One 2015;10:e0124555. [PMID: 25938517 DOI: 10.1371/journal.pone.0124555] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 8.6] [Reference Citation Analysis]
74 Dai X, Chen X, Chen Q, Shi L, Liang H, Zhou Z, Liu Q, Pang W, Hou D, Wang C. MicroRNA-193a-3p Reduces Intestinal Inflammation in Response to Microbiota via Down-regulation of Colonic PepT1. J Biol Chem. 2015;290:16099-16115. [PMID: 25931122 DOI: 10.1074/jbc.m115.659318] [Cited by in Crossref: 45] [Cited by in F6Publishing: 52] [Article Influence: 6.4] [Reference Citation Analysis]
75 Bergallo M, Gambarino S, Martino S, Montin D, Montanari P, Galliano I, Tovo PA. Comparison of Two Available RNA Extraction Protocols for microRNA Amplification in Serum Samples. J Clin Lab Anal 2016;30:277-83. [PMID: 25853736 DOI: 10.1002/jcla.21848] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
76 Mi S, Zhang J, Zhang W, Huang RS. Circulating microRNAs as biomarkers for inflammatory diseases. Microrna 2013;2:63-71. [PMID: 25019052 DOI: 10.2174/2211536611302010007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
77 Li JJ, Tay HL, Maltby S, Xiang Y, Eyers F, Hatchwell L, Zhou H, Toop HD, Morris JC, Nair P, Mattes J, Foster PS, Yang M. MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity. J Allergy Clin Immunol 2015;136:462-73. [PMID: 25772595 DOI: 10.1016/j.jaci.2014.11.044] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 8.6] [Reference Citation Analysis]
78 Deng X, Su Y, Wu H, Wu R, Zhang P, Dai Y, Chan T, Zhao M, Lu Q. The Role of MicroRNAs in Autoimmune Diseases with Skin Involvement. Scand J Immunol 2015;81:153-65. [DOI: 10.1111/sji.12261] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
79 Van der Goten J, Vanhove W, Lemaire K, Van Lommel L, Machiels K, Wollants WJ, De Preter V, De Hertogh G, Ferrante M, Van Assche G. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis. PLoS One. 2014;9:e116117. [PMID: 25546151 DOI: 10.1371/journal.pone.0116117] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
80 Yin Y, Cai X, Chen X, Liang H, Zhang Y, Li J, Wang Z, Chen X, Zhang W, Yokoyama S, Wang C, Li L, Li L, Hou D, Dong L, Xu T, Hiroi T, Yang F, Ji H, Zhang J, Zen K, Zhang CY. Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth. Cell Res 2014;24:1164-80. [PMID: 25223704 DOI: 10.1038/cr.2014.121] [Cited by in Crossref: 152] [Cited by in F6Publishing: 164] [Article Influence: 19.0] [Reference Citation Analysis]
81 Liu X, He F, Pang R, Zhao D, Qiu W, Shan K, Zhang J, Lu Y, Li Y, Wang Y. Interleukin-17 (IL-17)-induced microRNA 873 (miR-873) contributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin-editing enzyme. J Biol Chem 2014;289:28971-86. [PMID: 25183005 DOI: 10.1074/jbc.M114.577429] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
82 Kim H, Hwang SS, Uh Y, Kim J, Yoon KJ, Lee JY. A case associated with comorbidities among cerebral infarction, idiopathic thrombocytopenic purpura, and triple x syndrome. Turk J Haematol 2014;31:184-7. [PMID: 25035678 DOI: 10.4274/tjh.2013.0064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
83 Zeng L, Cui J, Wu H, Lu Q. The emerging role of circulating microRNAs as biomarkers in autoimmune diseases. Autoimmunity 2014;47:419-29. [PMID: 24953646 DOI: 10.3109/08916934.2014.929667] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
84 Zhai Z, Wu F, Chuang AY, Kwon JH. miR-106b fine tunes ATG16L1 expression and autophagic activity in intestinal epithelial HCT116 cells. Inflamm Bowel Dis. 2013;19:2295-2301. [PMID: 23899543 DOI: 10.1097/mib.0b013e31829e71cf] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
85 Yiş U, Tüfekçi UK, Genç Ş, Çarman KB, Bayram E, Topçu Y, Kurul SH. Expression Patterns of Micro-RNAs 146a, 181a, and 155 in Subacute Sclerosing Panencephalitis. J Child Neurol 2015;30:69-74. [DOI: 10.1177/0883073814531329] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
86 Xie Z, Chang C, Zhou Z. Molecular Mechanisms in Autoimmune Type 1 Diabetes: a Critical Review. Clinic Rev Allerg Immunol 2014;47:174-92. [DOI: 10.1007/s12016-014-8422-2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 6.6] [Reference Citation Analysis]
87 Chen WX, Ren LH, Shi RH. Expression of miR-124 in active Crohn's disease and validation of aryl hydrocarbon receptor as its target gene. Shijie Huaren Xiaohua Zazhi 2014; 22(11): 1622-1627 [DOI: 10.11569/wcjd.v22.i11.1622] [Reference Citation Analysis]
88 Tiburzy B, Kulkarni U, Hauser AE, Abram M, Manz RA. Plasma cells in immunopathology: concepts and therapeutic strategies. Semin Immunopathol 2014;36:277-88. [PMID: 24740168 DOI: 10.1007/s00281-014-0426-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
89 Rinaldi M, Perricone R, Blank M, Perricone C, Shoenfeld Y. Anti-Saccharomyces cerevisiae autoantibodies in autoimmune diseases: from bread baking to autoimmunity. Clin Rev Allergy Immunol 2013;45:152-61. [PMID: 23292495 DOI: 10.1007/s12016-012-8344-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
90 Omrane I, Kourda N, Stambouli N, Privat M, Medimegh I, Arfaoui A, Uhrhammer N, Bougatef K, Baroudi O, Bouzaienne H, Marrakchi R, Bignon YJ, Benammar-Elgaaied A. MicroRNAs 146a and 147b biomarkers for colorectal tumor's localization. Biomed Res Int 2014;2014:584852. [PMID: 24800242 DOI: 10.1155/2014/584852] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
91 Selmi C, Shoenfeld Y. Open questions in autoimmunity: discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting. BMC Med 2014;12:50. [PMID: 24642104 DOI: 10.1186/1741-7015-12-50] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
92 Elovitz MA, Brown AG, Anton L, Gilstrop M, Heiser L, Bastek J. Distinct cervical microRNA profiles are present in women destined to have a preterm birth. Am J Obstet Gynecol 2014;210:221.e1-11. [PMID: 24565431 DOI: 10.1016/j.ajog.2013.12.043] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
93 Chang C. Autoimmunity: from black water fever to regulatory function. J Autoimmun 2014;48-49:1-9. [PMID: 24491820 DOI: 10.1016/j.jaut.2013.12.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
94 Chang C. Unmet needs in the treatment of autoimmunity: from aspirin to stem cells. Autoimmun Rev 2014;13:331-46. [PMID: 24462645 DOI: 10.1016/j.autrev.2014.01.052] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
95 Moret I, Sánchez-Izquierdo D, Iborra M, Tortosa L, Navarro-Puche A, Nos P, Cervera J, Beltrán B. Assessing an improved protocol for plasma microRNA extraction. PLoS One 2013;8:e82753. [PMID: 24376572 DOI: 10.1371/journal.pone.0082753] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 6.6] [Reference Citation Analysis]
96 Iudicibus SD, Lucafò M, Martelossi S, Pierobon C, Ventura A, Decorti G. MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. World J Gastroenterol 2013; 19(44): 7947-7954 [PMID: 24307788 DOI: 10.3748/wjg.v19.i44.7947] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
97 Anbazhagan AN, Priyamvada S, Kumar A, Maher DB, Borthakur A, Alrefai WA, Malakooti J, Kwon JH, Dudeja PK. Translational repression of SLC26A3 by miR-494 in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2014;306:G123-31. [PMID: 24177028 DOI: 10.1152/ajpgi.00222.2013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
98 Ordas A, Kanwal Z, Lindenberg V, Rougeot J, Mink M, Spaink HP, Meijer AH. MicroRNA-146 function in the innate immune transcriptome response of zebrafish embryos to Salmonella typhimurium infection. BMC Genomics 2013;14:696. [PMID: 24112639 DOI: 10.1186/1471-2164-14-696] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 7.0] [Reference Citation Analysis]
99 Ghorpade DS, Sinha AY, Holla S, Singh V, Balaji KN. NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease. J Biol Chem. 2013;288:33037-33048. [PMID: 24092752 DOI: 10.1074/jbc.m113.492496] [Cited by in Crossref: 51] [Cited by in F6Publishing: 60] [Article Influence: 5.7] [Reference Citation Analysis]
100 Wang J, Zheng S, Xin N, Dou C, Fu L, Zhang X, Chen J, Zhang Y, Geng D, Xiao C, Cui G, Shen X, Lu Y, Wang J, Dong R, Qiao Y, Zhang Y. Identification of Novel MicroRNA Signatures Linked to Experimental Autoimmune Myasthenia Gravis Pathogenesis: Down-Regulated miR-145 Promotes Pathogenetic Th17 Cell Response. J Neuroimmune Pharmacol 2013;8:1287-302. [DOI: 10.1007/s11481-013-9498-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
101 Iborra M, Bernuzzi F, Correale C, Vetrano S, Fiorino G, Beltrán B, Marabita F, Locati M, Spinelli A, Nos P. Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease. Clin Exp Immunol. 2013;173:250-258. [PMID: 23607522 DOI: 10.1111/cei.12104] [Cited by in Crossref: 79] [Cited by in F6Publishing: 83] [Article Influence: 8.8] [Reference Citation Analysis]
102 Curtale G, Citarella F. Dynamic nature of noncoding RNA regulation of adaptive immune response. Int J Mol Sci 2013;14:17347-77. [PMID: 23975170 DOI: 10.3390/ijms140917347] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
103 Katsushima F, Takahashi A, Sakamoto N, Kanno Y, Abe K, Ohira H. Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients. Hepatol Res. 2013; Jul 9. [Epub ahead of print]. [PMID: 23834361 DOI: 10.1111/hepr.12198] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
104 Jernås M, Malmeström C, Axelsson M, Nookaew I, Wadenvik H, Lycke J, Olsson B. MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS). BMC Immunol 2013;14:32. [PMID: 23895517 DOI: 10.1186/1471-2172-14-32] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
105 Ksiazek-Winiarek DJ, Kacperska MJ, Glabinski A. MicroRNAs as novel regulators of neuroinflammation. Mediators Inflamm 2013;2013:172351. [PMID: 23983402 DOI: 10.1155/2013/172351] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
106 Singh RP, Massachi I, Manickavel S, Singh S, Rao NP, Hasan S, Mc Curdy DK, Sharma S, Wong D, Hahn BH. The role of miRNA in inflammation and autoimmunity. Autoimmun Rev. 2013;12:1160-1165. [PMID: 23860189 DOI: 10.1016/j.autrev.2013.07.003] [Cited by in Crossref: 175] [Cited by in F6Publishing: 181] [Article Influence: 19.4] [Reference Citation Analysis]
107 Achenza MI, Meda F, Brunetta E, Selmi C. Serum autoantibodies for the diagnosis and management of autoimmune liver diseases. Expert Rev Gastroenterol Hepatol. 2012;6:717-729. [PMID: 23237257 DOI: 10.1586/egh.12.58] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
108 Jimenez SA, Piera-Velazquez S. Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome. Autoimmun Rev 2013;12:1046-51. [PMID: 23684698 DOI: 10.1016/j.autrev.2013.04.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 5.2] [Reference Citation Analysis]
109 Gazouli M, Papaconstantinou I, Stamatis K, Vaiopoulou A, Zeglinas C, Vassiliou I, Giokas G, Tzathas C. Association study of genetic variants in miRNAs in patients with inflammatory bowel disease: preliminary results. Dig Dis Sci. 2013;58:2324-2328. [PMID: 23543085 DOI: 10.1007/s10620-013-2640-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
110 Xu WD, Pan HF, Li JH, Ye DQ. MicroRNA-21 with therapeutic potential in autoimmune diseases. Expert Opin Ther Targets 2013;17:659-65. [PMID: 23506112 DOI: 10.1517/14728222.2013.773311] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
111 Hu JY, Zhang J, Cui JL, Liang XY, Lu R, Du GF, Xu XY, Zhou G. Increasing CCL5/CCR5 on CD4+ T cells in peripheral blood of oral lichen planus. Cytokine. 2013;62:141-145. [PMID: 23490419 DOI: 10.1016/j.cyto.2013.01.020] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
112 Gheinani AH, Burkhard FC, Monastyrskaya K. Deciphering microRNA code in pain and inflammation: lessons from bladder pain syndrome. Cell Mol Life Sci 2013;70:3773-89. [PMID: 23463234 DOI: 10.1007/s00018-013-1275-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
113 Firth AL, Won JY, Park WS. Regulation of ca(2+) signaling in pulmonary hypertension. Korean J Physiol Pharmacol 2013;17:1-8. [PMID: 23439762 DOI: 10.4196/kjpp.2013.17.1.1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
114 Nair N, Kumar S, Gongora E, Gupta S. Circulating miRNA as novel markers for diastolic dysfunction. Mol Cell Biochem. 2013;376:33-40. [PMID: 23247724 DOI: 10.1007/s11010-012-1546-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 5.3] [Reference Citation Analysis]
115 Menegatti E, Berardi D, Messina M, Ferrante I, Giachino O, Spagnolo B, Restagno G, Cognolato L, Roccatello D. Lab-on-a-chip: emerging analytical platforms for immune-mediated diseases. Autoimmun Rev 2013;12:814-20. [PMID: 23219952 DOI: 10.1016/j.autrev.2012.11.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
116 Xiong Q, Xu L. Significance of serum microRNAs in patients with gastrointestinal diseases. Shijie Huaren Xiaohua Zazhi 2012; 20(22): 2043-2049 [DOI: 10.11569/wcjd.v20.i22.2043] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Zhang C, Jiang M, Lu A. Considerations of Traditional Chinese Medicine as Adjunct Therapy in the Management of Ulcerative Colitis. Clinic Rev Allerg Immunol 2013;44:274-83. [DOI: 10.1007/s12016-012-8328-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
118 Fernando TR, Rodriguez-Malave NI, Rao DS. MicroRNAs in B cell development and malignancy. J Hematol Oncol 2012;5:7. [PMID: 22401860 DOI: 10.1186/1756-8722-5-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
119 Bianchi I, Lleo A, Gershwin ME, Invernizzi P. The X chromosome and immune associated genes. J Autoimmun. 2012;38:J187-J192. [PMID: 22178198 DOI: 10.1016/j.jaut.2011.11.012] [Cited by in Crossref: 161] [Cited by in F6Publishing: 156] [Article Influence: 14.6] [Reference Citation Analysis]
120 Capuano M, Iaffaldano L, Tinto N, Montanaro D, Capobianco V, Izzo V, Tucci F, Troncone G, Greco L, Sacchetti L. MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce goblet cells characterize the small intestine of celiac patients. PLoS One. 2011;6:e29094. [PMID: 22194996 DOI: 10.1371/journal.pone.0029094] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 5.4] [Reference Citation Analysis]
121 Bogdanos DP, Rigopoulou EI, Smyk DS, Roggenbuck D, Reinhold D, Forbes A, Laass MW, Conrad K. Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies. Autoimmun Rev. 2011;11:143-148. [PMID: 21983481 DOI: 10.1016/j.autrev.2011.09.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
122 Tili E, Michaille JJ. Resveratrol, MicroRNAs, Inflammation, and Cancer. J Nucleic Acids. 2011;2011:102431. [PMID: 21845215 DOI: 10.4061/2011/102431] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
123 Selmi C. Autoimmunity in 2010. Autoimmun Rev. 2011;10:725-732. [PMID: 21763468 DOI: 10.1016/j.autrev.2011.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
124 Leng RX, Pan HF, Qin WZ, Chen GM, Ye DQ. Role of microRNA-155 in autoimmunity. Cytokine Growth Factor Rev 2011;22:141-7. [PMID: 21703910 DOI: 10.1016/j.cytogfr.2011.05.002] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 8.0] [Reference Citation Analysis]
125 O'neill LA, Sheedy FJ, Mccoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol 2011;11:163-75. [DOI: 10.1038/nri2957] [Cited by in Crossref: 593] [Cited by in F6Publishing: 600] [Article Influence: 53.9] [Reference Citation Analysis]
126 Meda F, Folci M, Baccarelli A, Selmi C. The epigenetics of autoimmunity. Cell Mol Immunol 2011;8:226-36. [PMID: 21278766 DOI: 10.1038/cmi.2010.78] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 10.8] [Reference Citation Analysis]
127 Tufekci KU, Oner MG, Genc S, Genc K. MicroRNAs and Multiple Sclerosis. Autoimmune Dis 2010;2011:807426. [PMID: 21188194 DOI: 10.4061/2011/807426] [Cited by in Crossref: 20] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]